Descrição
Crosstalk between angiogenesis and immune regulation in the tumor microenvironment
Tumour vascular targeting
Hallmarks of Cancer: The Next Generation: Cell
Frontiers IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation: Molecular Therapy
Interleukins in cancer: from biology to therapy
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
IL-3 is a novel target to interfere with tumor vasculature - Document - Gale Academic OneFile
HLA-G/LILRBs: A Cancer Immunotherapy Challenge: Trends in Cancer
de
por adulto (o preço varia de acordo com o tamanho do grupo)
